Champignon Appoints Dr Bill Wilkerson To Board Of Directors

Champignon Brands (CSE: SHRM) this morning continued its ongoing process of strengthening its board of directors with accomplished executives and thought leaders in the medical space with the appointment of Dr Bill Wilkerson, LL.D (Hon).

Dr Wilkerson is a highly accomplished executive in the areas of business, government, broadcasting, arts, and corporate crisis management. He has been an 8-time award-winner in workplace mental health, following an international initiative conducted from 1998 to 2012 to enforce the significance of mental health among major employers.

In terms of previous employment, Dr Wilkerson was previously President of Liberty Health, one of Canada’s largest benefits providers, and held executive roles at RBC, CBC, and the Toronto Symphony Orchestra. As an adviser for mental health, his career has been just as impressive, having worked with the NHL, the CFL, the Hockey Hall of Fame, Toronto Blue Jays, TSN, CTV, and more.

"I am pleased to join the board of directors of Champignon to help deploy, at long last, treatments of depression that work, work fast, restore health, fuel hope, animate workplace productivity, and save lives. The mission of this company is fundamental and enduring; to meet a pressing public need. This is what my twenty-two years of advocacy for mental health in the workplace has been all about. This directorship also permits me to support and help facilitate the vision of the extraordinarily skilled and dedicated physician-scientist Dr. Roger McIntyre, a world leader in a field that cries out for his kind of resolve, courage, compassion, and knowledge. I am humbled by, and grateful for, the opportunity to serve." 
Dr Bill Wilkerson

In conjunction with the appointment of Dr Bill Wilkerson, Joe Perino has resigned from Champignon’s board of directors.

Champignon Brands last traded at $1.63 on the CSE.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Artemis Gold Q3 Earnings: Growth Already In Focus

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Recommended

Kalshi Faces Class Action Lawsuit Over Alleged Illegal Sports Betting

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Related News

Champignon Brands Announces Contract Research Partner For Ketamine, Psilocybin IP Portfolio

Champignon Brands (CSE: SHRM) announced this morning that it is advancing its drug discovery program...

Monday, June 8, 2020, 10:03:37 AM

Champignon Brands Announces Name Change, Spin Out Of CPG Division

Champignon Brands (CSE: SHRM) announced after the bell last night that it intends to change...

Saturday, June 13, 2020, 11:39:46 AM

Champignon Brands Appoints Dr Roger McIntyre As CEO

Champignon Brands (CSE: SHRM) this morning announced that it has named Dr Roger McIntyre as...

Monday, May 11, 2020, 09:48:09 AM

Champignon Brands To Acquire Artisan Growers

Champignon Brands (CSE: SHRM) has entered into a definitive agreement to acquire that of Artisan...

Monday, March 16, 2020, 10:18:13 AM

Harvest Moon: Reducing Suicidal Ideation With Ketamine Infusions

Suicidal ideation is an emergent condition that demands immediate attention. It has been shown that...

Tuesday, May 26, 2020, 03:00:00 PM